Business Description
![Clene Inc Clene Inc logo](https://static.gurufocus.com/logos/0C0000C1B0.png?14)
Clene Inc
NAICS : 311999
SIC : 2834
ISIN : US1856341029
Share Class Description:
FRA:84C0: Ordinary SharesDescription
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | -0.01 | |||||
Debt-to-Equity | -64.72 | |||||
Debt-to-EBITDA | -1.37 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -10.62 | |||||
Beneish M-Score | -3.24 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19 | |||||
3-Year EBITDA Growth Rate | 24.8 | |||||
3-Year EPS without NRI Growth Rate | 19.1 | |||||
3-Year FCF Growth Rate | 35.9 | |||||
3-Year Book Growth Rate | 162.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 33.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 377.74 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.81 | |||||
9-Day RSI | 63.08 | |||||
14-Day RSI | 55.47 | |||||
6-1 Month Momentum % | -46.92 | |||||
12-1 Month Momentum % | -66.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 232.04 | |||||
Days Sales Outstanding | 81.75 | |||||
Days Payable | 6039.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.2 | |||||
Shareholder Yield % | -4.58 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81 | |||||
Operating Margin % | -7806.11 | |||||
Net Margin % | -6890.5 | |||||
FCF Margin % | -6216.87 | |||||
ROE % | -253.42 | |||||
ROA % | -57.24 | |||||
ROIC % | -113.28 | |||||
ROC (Joel Greenblatt) % | -190.5 | |||||
ROCE % | -77.2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 79.41 | |||||
EV-to-EBIT | -1.84 | |||||
EV-to-Forward-EBIT | -1.35 | |||||
EV-to-EBITDA | -1.96 | |||||
EV-to-Forward-EBITDA | -1.33 | |||||
EV-to-Revenue | 105.9 | |||||
EV-to-Forward-Revenue | 97.73 | |||||
EV-to-FCF | -1.67 | |||||
Earnings Yield (Greenblatt) % | -54.45 | |||||
FCF Yield % | -76.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clene Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.409 | ||
EPS (TTM) (€) | -4.116 | ||
Beta | -0.24 | ||
Volatility % | 121.19 | ||
14-Day RSI | 55.47 | ||
14-Day ATR (€) | 0.181758 | ||
20-Day SMA (€) | 4.295 | ||
12-1 Month Momentum % | -66.76 | ||
52-Week Range (€) | 3.555 - 13.8 | ||
Shares Outstanding (Mil) | 6.47 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clene Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clene Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Clene Inc Frequently Asked Questions
What is Clene Inc(FRA:84C0)'s stock price today?
The current price of FRA:84C0 is €4.76. The 52 week high of FRA:84C0 is €13.80 and 52 week low is €3.56.
When is next earnings date of Clene Inc(FRA:84C0)?
The next earnings date of Clene Inc(FRA:84C0) is 2024-11-07 Est..
Does Clene Inc(FRA:84C0) pay dividends? If so, how much?
Clene Inc(FRA:84C0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |